Arkolith/Insider Trading/ATXI/Form 4

Fortress Biotech, Inc.

10% OwnerAVENUE THERAPEUTICS, INC. (ATXI) · full profile →Form 4 · filed Jan 4, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 3, 2023Grant(A)231K—$0562K
Dec 31, 2022Grant(A)91K—$0330K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-23-000998) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML